CA SB 524 Comment Letter (2021)
PCMA delivers a comment letter to the chair of the Assembly committee on Business and Professions addressing steering and mail order proposed provisions.
OK Coalition Comment Letter to BoP (2023)
Coalition letter in opposition to a Board of Pharmacy proposed rule that would require temperature controlled packaging for all drug delivery, regardless of specific temperature
ND SB 2378 Cost Analysis (2023)
Cost analysis for provisions relating to preferred networks and mail order pharmacy restrictions and a white bagging prohibition.
MA Bundle of Bills Testimony (2021)
PCMA submits testimny to the Joint Committee on Financial Services regarding a bucket list of bills addressing a wide range of PBM regulations.
IA HF 729 Cost Analysis (2021)
If enacted, IA HF 729 would cost the state $1.2 billion over next 10 years. HF 729 would instittue Any Willing Provider rules and restrict
CA SB 524 Comment Letter
PCMA delivers a comment letter to the sponsor of SB 602, a bill that aims to prohibit PBMs ability to steer patients to lower cost,
CA SB 524 Comment Letter
PCMA provides comment letter to the CA Senate Health Committee opposing SB 524, an anti-steering bill. If enacted, the bill would prohibit PBMs from offering
PCMA Comment Letter OR HB 485 (2019)
This letter was submitted by PCMA regarding OR HB485 dealing with mail order pharmacies and clarification on the pharmacy appeal process.